Lefetamine
| Lefetamine | |
|---|---|
| Salts [] | |
|---|---|
| Lefetamine hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 225.33 g/mol [1] |
| Predicted LogP | 3.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H19N |
| IUPAC name | (1R)-N,N-dimethyl-1,2-diphenylethanamine |
| SMILES | CN(C)[C@H](CC1=CC=CC=C1)C2=CC=CC=C2 |
| InChI | InChI=1S/C16H19N/c1-17(2)16(15-11-7-4-8-12-15)13-14-9-5-3-6-10-14/h3-12,16H,13H2,1-2H3/t16-/m1/s1 |
| InChIKey | YEJZJVJJPVZXGX-MRXNPFEDSA-N |
| CAS number | 7262-75-1 |
| UNII | 4J9726V5Y9 |
| PubChem CID | 443970 |
| Pharmacokinetics[] | |
|---|---|
| Routes of administration | Oral |
Lefetamine (also known as Lefetamina, Lephetamine, Lefetaminum, Santenol, lephetamine,, (-)-N,N-Dimethyl-1,2-diphenylethylamine, DEA No. 1635, dl-N,N-Dimethyl-1,2-diphenyl-ethylamine, [(1R)-1,2-diphenylethyl]dimethylamine or Ethylamine, n,n-dimethyl-1,2-diphenyl-, (-)-) is a substance of the 1,2-diarylethylamine class.
Chemistry
Salts []
Lefetamine is typically found in the form of its hydrochloride salt.
Stereochemistry []
Lefetamine is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Lefetamine matches Lipinski's rule of five.Legal status []
- Australia: Lefetamine is a Schedule 4.
- Brazil: Lefetamine is a B1.[3]
- Canada: Lefetamine is a Schedule III.
- United States: Lefetamine is a Schedule IV under the "Controlled Substances Act".
- United Kingdom: Lefetamine is a Class B under the "Misuse of Drugs Act 1971".
- Germany: Lefetamine is a Anlage I under the "Betäubungsmittelgesetz (BtMG)".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 443970, Lefetamine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/443970
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Lefetamine. UNII: 4J9726V5Y9. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4J9726V5Y9
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 14:01:03 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 14:00:59 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 14:00:59 |
| gsrs | ok | 2026-11-20 14:01:01 |
| hmdb | missing (no HMDB id) | 2026-11-20 14:00:59 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 14:01:03 |
| pubchem | ok | 2026-11-20 14:00:59 |
| missing (no r/tripreports posts mention it) | 2026-11-20 14:00:59 | |
| sider | missing (not in SIDER) | 2026-11-20 14:00:59 |
| structure | ok | 2026-11-20 14:00:59 |
| wikipedia | ok | 2026-11-20 14:00:59 |